Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
32,362,647
-
Share change
-
+1,078,046
-
Total reported value
-
$825,902,832
-
Put/Call ratio
-
330%
-
Price per share
-
$25.52
-
Number of holders
-
142
-
Value change
-
+$18,356,861
-
Number of buys
-
83
-
Number of sells
-
57
Institutional Holders of ACCELERON PHARMA INC - COMMON STOCK (XLRN) as of Q4 2016
As of 31 Dec 2016,
ACCELERON PHARMA INC - COMMON STOCK (XLRN) was held by
142 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,362,647 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Fund Advisors, WESTFIELD CAPITAL MANAGEMENT CO LP, Novo A/S, EAGLE ASSET MANAGEMENT INC, OAK RIDGE INVESTMENTS LLC, STATE STREET CORP, and BlackRock Advisors LLC.
This page lists
142
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.